1. Home
  2. COOK vs ALEC Comparison

COOK vs ALEC Comparison

Compare COOK & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Traeger Inc.

COOK

Traeger Inc.

HOLD

Current Price

$1.17

Market Cap

145.2M

ML Signal

HOLD

Logo Alector Inc.

ALEC

Alector Inc.

HOLD

Current Price

$1.94

Market Cap

200.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
COOK
ALEC
Founded
1985
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Wholesale Distributors
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
145.2M
200.8M
IPO Year
2021
2019

Fundamental Metrics

Financial Performance
Metric
COOK
ALEC
Price
$1.17
$1.94
Analyst Decision
Hold
Hold
Analyst Count
7
7
Target Price
$2.04
$3.33
AVG Volume (30 Days)
383.1K
1.0M
Earning Date
03-05-2026
02-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$582,799,000.00
$69,048,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
12.26
52 Week Low
$0.71
$0.87
52 Week High
$2.70
$3.40

Technical Indicators

Market Signals
Indicator
COOK
ALEC
Relative Strength Index (RSI) 62.28 69.62
Support Level $1.02 $1.77
Resistance Level $1.14 $2.00
Average True Range (ATR) 0.07 0.11
MACD 0.02 0.01
Stochastic Oscillator 100.00 85.57

Price Performance

Historical Comparison
COOK
ALEC

About COOK Traeger Inc.

Traeger Inc designs, sources, sells, and supports wood pellet fueled barbeque grills sold to retailers, distributors, and direct to consumers. It produces and sells the pellets used to fire the grills and also sells Traeger-branded rubs, spices, and sauces, as well as grilling accessories including covers, barbeque tools, trays, liners, and merchandise. The company's geographical segments include North America and the Rest of the world, of which majority of revenue is from North America.

About ALEC Alector Inc.

Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.

Share on Social Networks: